SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001348362-24-000001
Filing Date
2024-07-30
Accepted
2024-07-30 11:12:28
Documents
1
Period of Report
2024-07-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 13159
  Complete submission text file 0001348362-24-000001.txt   14747
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 235 WESTVALE DRIVE WATERLOO A6 N2T 1Y1
Business Address
McKechnie William Edward (Reporting) CIK: 0001658613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 241155501